Wikidata:Database reports/Complex constraint violations/P10245
Jump to navigation
Jump to search
Complex constraint violations report for MedlinePlus drug identifier (discussion, uses, items, changes): identifier for a drug in the MedlinePlus database
Data time stamp: (UTC)
The report is generated based on the settings on Property talk:P10245.
Updates overwrite this page. Some may already be fixed since the last update: check RecentChangesLinked.
The report can include false positives. No need to "fix" them.
Chemical entities with no indication of use as a drug[edit]
Chemical entities with no indication of use as a drug
Every item with MedlinePlus drug identifier (P10245) statement and instance of (P31)type of chemical entity (Q113145171) that has no has use (P366)medication (Q12140). In combination with other constraints it would allow in the future to properly move pharmacology-related statements from items about groups of isomers to items about specific isomer or to items about mixtures of isomers.
Every item with MedlinePlus drug identifier (P10245) statement and instance of (P31)type of chemical entity (Q113145171) that has no has use (P366)medication (Q12140). In combination with other constraints it would allow in the future to properly move pharmacology-related statements from items about groups of isomers to items about specific isomer or to items about mixtures of isomers.
92 violations
Query time: 0.30 s
- magnesium citrate (Q45044)
- valproic acid (Q240642)
- barium sulfate (Q309038)
- adefovir (Q353551)
- levalbuterol (Q408709)
- benzoyl peroxide (Q411424)
- chloral hydrate (Q412340)
- benzatropine (Q415026)
- medroxyprogesterone (Q416667)
- simethicone (Q419415)
- cannabidiol (Q422917)
- ranitidine (Q423037)
- mesna (Q424997)
- glimepiride (Q425027)
- aclidinium (Q521173)
- cabozantinib (Q795057)
- istradefylline (Q905783)
- pramoxine (Q1240076)
- tobramycin (Q1758380)
- allopregnanolone (Q2482223)
- cefotetan (Q2602246)
- olopatadine (Q3267092)
- mipomersen parent acid (Q3315722)
- clobetasol (Q4224007)
- lasmiditan (Q6493750)
- magnesium gluconate (Q6731392)
- pretomanid (Q7118312)
- pimavanserin (Q7194603)
- retapamulin (Q7316645)
- Romosozumab (Q7363297)
- fedratinib (Q7670147)
- tedizolid (Q7825683)
- Valsartan/hydrochlorothiazide (Q7912612)
- cromolyn sodium (Q10261779)
- betaine (Q10860583)
- cabotegravir (Q15411012)
- Anifrolumab (Q15708296)
- fostemsavir (Q17001240)
- Ponesimod (Q18604129)
- Evinacumab (Q19904115)
- Polatuzumab vedotin (Q19946115)
- lemborexant (Q20707990)
- lumateperone (Q21098913)
- relugolix (Q21099000)
- finerenone (Q21099046)
- lefamulin (Q24890013)
- tucatinib (Q25100690)
- Brolucizumab (Q25326694)
- upadacitinib (Q27074125)
- azilsartan (Q27074832)
- bempedoic acid (Q27075007)
- ripretinib (Q27076996)
- opicapone (Q27088208)
- tepotinib (Q27088961)
- omacetaxine (Q27106125)
- fluocinolone (Q27106662)
- penicillin v potassium (Q27107637)
- mycophenolate (Q27132295)
- ceftaroline (Q27139048)
- trifarotene (Q27236856)
- trospium chloride (Q27252312)
- pirbuterol acetate (Q27252326)
- lurbinectedin (Q27254568)
- selinexor (Q27256082)
- telotristat (Q27256725)
- semaglutide (Q27261089)
- strontium chloride sr-89 (Q27262770)
- ulipristal (Q27264992)
- belumosudil (Q27269397)
- rimegepant (Q27272184)
- ubrogepant (Q27273878)
- melphalan flufenamide (Q27277739)
- diroximel fumarate (Q27281786)
- vericiguat (Q27283201)
- vibegron (Q27283524)
- cenobamate (Q27286352)
- cefiderocol (Q27289472)
- maralixibat (Q27291331)
- brigatinib (Q27456393)
- belzutifan (Q27456641)
- Burosumab (Q28209068)
- avapritinib (Q29213676)
- beclometasone (Q31948091)
- fludarabine (Q72478349)
- loteprednol (Q72487729)
- sotorasib (Q75175937)
- Magnesium sulfate mixture with potassium sulfate and sodium sulfate (Q83020672)
- Glatiramer (Q83053564)
- pralsetinib (Q97732199)
- mobocertinib (Q105338009)
- trilaciclib (Q105592965)
- Margetuximab (Q109356831)